2010
DOI: 10.1016/j.ydbio.2010.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Neurogenin 1 (Neurog1) expression in the ventral neural tube is mediated by a distinct enhancer and preferentially marks ventral interneuron lineages

Abstract: The bHLH transcription factor Neurog1 (Ngn1, Neurod3, neurogenin 1) is involved in neuronal differentiation and cell-type specification in distinct regions of the developing nervous system. Here, transgenic mouse models were developed that use a Bacterial Artificial Chromosome (BAC) containing 208 kb flanking the Neurog1 gene to efficiently drive expression of GFP and Cre in all Neurog1 domains. Two characteristics of Neurog1 gene regulation were uncovered. First, a 4 kb region previously shown to be sufficien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
42
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(43 citation statements)
references
References 55 publications
1
42
0
Order By: Relevance
“…To determine whether Shh produced by the spiral ganglion affects cochlear development, we generated ganglionspecific knockouts using three different cre strains: Foxg1 Cre , Ngn1 Cre , and Ngn1 CreERT2 (16)(17)(18). Neurogenin1 (Ngn1) expression is initiated in neuroblasts of the CVG before their delamination from the otic epithelium (19).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To determine whether Shh produced by the spiral ganglion affects cochlear development, we generated ganglionspecific knockouts using three different cre strains: Foxg1 Cre , Ngn1 Cre , and Ngn1 CreERT2 (16)(17)(18). Neurogenin1 (Ngn1) expression is initiated in neuroblasts of the CVG before their delamination from the otic epithelium (19).…”
Section: Resultsmentioning
confidence: 99%
“…Foxg1 is expressed in the otocyst and CVG (16). Based on published cre reporter activities, all three cre strains should ablate Shh expression in the CVG (16)(17)(18) while sparing its expression in the notochord and floor plate, two sources of Shh thought to be required for specification of cochlear identity (10,11).…”
Section: Resultsmentioning
confidence: 99%
“…and M.G., unpublished), Ai14 (R26 floxstop-tdTomato ) (Madisen et al, 2010), Foxd3 flox/flox (Teng et al, 2008), Oc1 -/-;Oc2 lacZ/lacZ (Clotman et al, 2005), Nes::Cre (Tronche et al, 1999), Ngn1::Cre (Quinones et al, 2010), ZnG (Zhang et al, 2008) and MafB GFP (Blanchi et al, 2003). PCR genotyping was undertaken with allele-specific primers for each strain.…”
Section: Micementioning
confidence: 99%
“…The ability of genomic constructs to drive tissue-and time-specific expression, unlike cDNA and mini-genes, has made BAC transgenics an additional tool to knockout transgenics for the identification of potential regulatory elements within the locus of a gene. For instance, an enhancer within the locus of the tyrosinase-related family (Tyrp1) gene (Murisier et al, 2006) and a region responsible for tissue-specific expression within the locus of the Neurogenin1 gene (Quiñones et al, 2010) have been discovered in transgenic mice generated with BACs.…”
Section: Advantages Of Use Of Genomic Constructs In Gene Therapymentioning
confidence: 99%